FF
IONS icon

FourThought Financial’s Ionis Pharmaceuticals IONS Stock Holding History

FourThought Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27
Closed -$1K – 1509
2022
Q1 		$1K Hold
27
– – ﹤0.01% 1401
2021
Q4 		$1K Sell
27
-250
-90% -$7.87K ﹤0.01% 1436
2021
Q3 		$9K Hold
277
– – ﹤0.01% 1117
2021
Q2 		$11K Hold
277
– – ﹤0.01% 1085
2021
Q1 		$12K Sell
277
-48
-15% -$2.68K ﹤0.01% 1015
2020
Q4 		$18K Buy
+325
New +$16.2K ﹤0.01% 900

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

FourThought Financial's IONS Position: Q2 2022 in Review

FourThought Financial sold out of Ionis Pharmaceuticals (IONS) in Q2 2022, closing a stake of 27 shares — an estimated $1K sold.

FourThought Financial first reported a position in IONS in Q4 2020 and held it in 6 quarters. The position peaked at $18K in Q4 2020. 350 funds tracked by Wall St. Rank hold IONS as of Q2 2022.

  • FourThought Financial reported no remaining Ionis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • FourThought Financial sold 27 Ionis Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • FourThought Financial first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • FourThought Financial's Ionis Pharmaceuticals position peaked at $18K in Q4 2020.
  • 350 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2022.

Based on FourThought Financial's 13F filing for Q2 2022, filed 12 Aug 2022.